Rigel Pharmaceuticals
Patents, Design & Utilities
Last updated:
List of all Rigel Pharmaceuticals patents 117 in total
| Status | Patent |
|---|---|
Grant | Utility: Nrf2 activating compounds and uses thereof Filling date: 26 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: AMPK-activating heterocyclic compounds and methods for using the same Filling date: 26 Sep 2025 Issue date: 9 Mar 2021 |
Grant | Utility: IRAK inhibitors and method for making and using Filling date: 26 Sep 2025 Issue date: 9 Mar 2021 |
Application | Utility: PYRAZOLE COMPOUNDS, FORMULATIONS THEREOF, AND A METHOD FOR USING THE COMPOUNDS AND/OR FORMULATIONS Filling date: 26 Sep 2025 Issue date: 4 Mar 2021 |
Application | Utility: RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME Filling date: 26 Sep 2025 Issue date: 11 Feb 2021 |
Application | Utility: RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME Filling date: 26 Sep 2025 Issue date: 14 Jan 2021 |
Grant | Utility: Prodrugs of Nrf2 activating compounds and uses thereof Filling date: 26 Sep 2025 Issue date: 12 Jan 2021 |
Application | Utility: RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME Filling date: 26 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME Filling date: 26 Sep 2025 Issue date: 7 Jan 2021 |
Application | Utility: RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME Filling date: 26 Sep 2025 Issue date: 31 Dec 2020 |
Grant | Utility: 2,3-Disubstituted pyridine compounds as TGF-.beta. inhibitors and methods of use Filling date: 26 Sep 2025 Issue date: 8 Dec 2020 |
Application | Utility: METHOD OF PREVENTING AND TREATING THROMBOSIS Filling date: 26 Sep 2025 Issue date: 3 Dec 2020 |
Grant | Utility: Tyrosine kinase inhibitors Filling date: 26 Sep 2025 Issue date: 1 Dec 2020 |
Application | Utility: Prodrugs of Nrf2 Activating Compounds and Uses Thereof Filling date: 26 Sep 2025 Issue date: 26 Nov 2020 |
Grant | Utility: Nrf2 activating compounds and uses thereof Filling date: 26 Sep 2025 Issue date: 24 Nov 2020 |
Grant | Utility: 2,4-pyrimidinediamine compounds and their uses Filling date: 26 Sep 2025 Issue date: 10 Nov 2020 |
Grant | Utility: TGF-.beta. inhibitorC Filling date: 26 Sep 2025 Issue date: 3 Nov 2020 |
Application | Utility: BENZAZOLE COMPOUNDS AND METHODS FOR MAKING AND USING THE COMPOUNDS Filling date: 26 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: ANTIGEN BINDING MOLECULES TO TIGIT Filling date: 26 Sep 2025 Issue date: 29 Oct 2020 |
Application | Utility: Nrf2 Activating Compounds and Uses Thereof Filling date: 26 Sep 2025 Issue date: 29 Oct 2020 |
Grant | Utility: RIP1 inhibitory compounds and methods for making and using the same Filling date: 26 Sep 2025 Issue date: 27 Oct 2020 |
Grant | Utility: Protein kinase C inhibitors and uses thereof Filling date: 26 Sep 2025 Issue date: 6 Oct 2020 |
Application | Utility: 2,4-DIAMINO-PYRIMIDINE COMPOUNDS AND METHOD FOR MAKING AND USING THE COMPOUNDS Filling date: 26 Sep 2025 Issue date: 24 Sep 2020 |
Grant | Utility: Prodrugs of NRF2 activating compounds and uses thereof Filling date: 26 Sep 2025 Issue date: 15 Sep 2020 |
Grant | Utility: Benzazole compounds and methods for making and using the compounds Filling date: 26 Sep 2025 Issue date: 15 Sep 2020 |
Grant | Utility: Antigen binding molecules to TIGIT Filling date: 26 Sep 2025 Issue date: 1 Sep 2020 |
Application | Utility: PRODRUGS OF 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES Filling date: 26 Sep 2025 Issue date: 27 Aug 2020 |
Grant | Utility: 2,4-pyrimidinediamine compounds and their uses Filling date: 26 Sep 2025 Issue date: 14 Jul 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY Filling date: 26 Sep 2025 Issue date: 9 Jul 2020 |
Application | Utility: Nrf2 Activating Compounds and Uses Thereof Filling date: 26 Sep 2025 Issue date: 9 Jul 2020 |
Grant | Utility: Fused imidazole derivatives as TGF-beta inhibitors Filling date: 26 Sep 2025 Issue date: 30 Jun 2020 |
Application | Utility: KINASE INHIBITORS AND METHODS FOR MAKING AND USING Filling date: 26 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY Filling date: 26 Sep 2025 Issue date: 11 Jun 2020 |
Application | Utility: Fumarate Analogs and Uses Thereof Filling date: 26 Sep 2025 Issue date: 21 May 2020 |
Grant | Utility: Nrf2 activating compounds and uses thereof Filling date: 26 Sep 2025 Issue date: 12 May 2020 |
Application | Utility: COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY Filling date: 26 Sep 2025 Issue date: 16 Apr 2020 |
Application | Utility: 2,4-PYRIMIDINEDIAMINE COMPOUNDS AND THEIR USES Filling date: 26 Sep 2025 Issue date: 19 Mar 2020 |
Application | Utility: COMPOUNDS AND METHOD FOR TREATING AUTOIMMUNE DISEASES Filling date: 26 Sep 2025 Issue date: 19 Mar 2020 |
Grant | Utility: Kinase inhibitors and methods for making and using Filling date: 26 Sep 2025 Issue date: 17 Mar 2020 |
Application | Utility: TYROSINE KINASE INHIBITORS Filling date: 26 Sep 2025 Issue date: 12 Mar 2020 |
Grant | Utility: Prodrugs of 2,4-pyrimidinediamine compounds and their uses Filling date: 26 Sep 2025 Issue date: 3 Mar 2020 |
Grant | Utility: Compositions and methods for inhibition of the JAK pathway Filling date: 26 Sep 2025 Issue date: 11 Feb 2020 |
Grant | Utility: Nrf2 activating compounds and uses thereof Filling date: 26 Sep 2025 Issue date: 11 Feb 2020 |
Application | Utility: TGF-Beta Inhibitors Filling date: 26 Sep 2025 Issue date: 30 Jan 2020 |
Application | Utility: AMPK-ACTIVATING HETEROCYCLIC COMPOUNDS AND METHODS FOR USING THE SAME Filling date: 26 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: Prodrugs of 2,4-Pyrimidinediamine Compounds and Their Uses Filling date: 26 Sep 2025 Issue date: 16 Jan 2020 |
Application | Utility: Tyrosine Kinase Inhibitors Filling date: 26 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: ACVR2A-SPECIFIC ANTIBODY AND METHOD OF USE THEREOF Filling date: 26 Sep 2025 Issue date: 19 Dec 2019 |
Application | Utility: Prodrugs of NRF2 Activating Compounds and Uses Thereof Filling date: 26 Sep 2025 Issue date: 5 Dec 2019 |
Grant | Utility: Fumarate analogs and uses thereof Filling date: 26 Sep 2025 Issue date: 3 Dec 2019 |
Showing 50 to 100 of 117 patents.